TITLE

Adherence to HAART Among HIV-Infected Persons in Rural Louisiana

AUTHOR(S)
Mohammed, Hamish; Kieltyka, Lyn; Richardson-Alston, Gwangi; Magnus, Manya; Fawal, Hala; Vermund, Sten H.; Rice, Janet; Kissinger, Patricia
PUB. DATE
May 2004
SOURCE
AIDS Patient Care & STDs;May2004, Vol. 18 Issue 5, p289
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of this study was to examine factors associated with nonadherence to highly active antiretroviral therapy (HAART) in patients seen in HIV clinics throughout nonurban Louisiana. A convenience sample of 273 patients from 8 areas in nonurban Louisiana were interviewed to obtain demographic, clinical and adherence information. Associations between demographic, clinical, and behavioral factors and nonadherence were examined. Ideally, nonadherence should not exceed 5% in patients for whom HAART was prescribed. Mean age was 38.6 years (range, 19–66), 29.3% were female, 60.1% were African American, 34.4% reported nonadherence to their HAART medication (defined as the subject's self-report of missing any doses of HAART medication in the prior week). In the prior month, participants reported the following behaviors: binge drinking (12.8%), problem drinking (12.8%), and illicit drug use (16.5%). Depression was found in 49.8% of the respondents. In logistic regression analysis, problem drinking odds ratio [OR] (95% confidence interval [CI]): 3.92 (1.69,9.09) was found to be associated with nonadherence. Demographic and behavioral factors such as illicit drug use and depression were not associated with nonadherence on multivariable analysis. Problem drinking was associated with lack of adherence to HAART over the past week. Interventions to treat problem drinking are needed and may improve adherence to medication for HIV-infected persons living in rural, town, and small-city areas.
ACCESSION #
13167287

 

Related Articles

  • Study finds intensive coaching improves antiretroviral therapy adherence.  // American Journal of Health-System Pharmacy;9/1/2002, Vol. 59 Issue 17, p1600 

    The article examines a study by researchers at the University of Buffalo (UB) that found a sharp decrease in viral load among newly diagnosed HIV-positive patients who received intensive medication-adherence coaching from pharmacists in the first 16 weeks of therapy. The study showed that an...

  • Nonadherence to Antiretroviral Therapy in HIV-Positive Patients in Costa Rica. Stout, Brian Douglas; Leon, Maria Paz; Niccolai, Linda M. // AIDS Patient Care & STDs;May2004, Vol. 18 Issue 5, p297 

    A cross-sectional study was performed among seropositive individuals who sought HIV treatment at an outpatient clinic in San Jose, Costa Rica, to determine the prevalence, predictors, and reasons for nonadherence to antiretroviral. A structured, face-to-face interview was administered to 88...

  • Psychiatric and Social Barriers to HIV Medication Adherence in a Triply Diagnosed Methadone Population. Palmer, Nancy B.; Salcedo, Jesus; Miller, Alec L.; Winiarski, Mark; Arno, Peter // AIDS Patient Care & STDs;Dec2003, Vol. 17 Issue 12, p635 

    Although antiretrovirals can prolong life, medication adherence also poses a constant challenge for HIV-infected individuals because the success of antiretroviral regimens demands nearly perfect adherence to medications. This paper describes the psychiatric and social barriers to adherence in a...

  • NEAR-PERFECT ADHERENCE NEEDED TO SUPPRESS CELL-ASSOCIATED HIV. Carter, Michael // HIV Australia;2012, Vol. 10 Issue 2, p49 

    The article focuses on a Netherlands report of investigators in the online edition of the "Journal of Infectious Diseases" showing the need of complete adherence to antiretroviral therapy (ART) in ensuring suppression of cell-associated HIV. The report has examined an average of 40 people taking...

  • Psychosocial Assessments for HIV+ African Adolescents: Establishing Construct Validity and Exploring Under-Appreciated Correlates of Adherence. Lowenthal, Elizabeth D.; Marukutira, Tafireyi C.; Chapman, Jennifer; Mokete, Keboletse; Riva, Katherine; Tshume, Ontibile; Eby, Jessica; Matshaba, Mogomotsi; Anabwani, Gabriel M.; Gross, Robert; Glanz, Karen // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Study Objectives: Psychosocial factors such as outcome expectancy, perceived stigma, socio-emotional support, consideration of future consequences, and psychological reactance likely influence adolescent adherence to antiretroviral treatments. Culturally-adapted and validated tools for...

  • Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living Project. Johnson, Mallory O.; Catz, Sheryl L.; Remien, Robert H.; Rotheram-Borus, Mary Jane; Morin, Stephen F.; Charlebois, Edwin; Gore-Felton, Cheryl; Goldsten, Rise B.; Wolfe, Hannah; Lightfoot, Marguerita; Chesney, Margaret A. // AIDS Patient Care & STDs;Dec2003, Vol. 17 Issue 12, p645 

    Objectives: Adherence to antiretroviral therapy (ART) remains a challenge in efforts to maximize HIV treatment benefits. Previous studies of antiretroviral adherence are limited by low statistical power, homogeneous samples, and biased assessment methods. Based on Social Action Theory and using...

  • Lipodystrophy Severity Does Not Contribute to HAART Nonadherence. Collins, Evan J.; Burgoyne, Robert W.; Wagner, Cheryl A.; Abbey, Susan E.; Halman, Mark H.; Nur, Margaret L.; Walmsley, Sharon L. // AIDS & Behavior;May2006, Vol. 10 Issue 3, p273 

    Lipodystrophy severity among 77 people living with HIV/AIDS (PHA) with body fat redistribution was not related to antiretroviral adherence including doses missed during the previous month, categorical rating of maximal adherence, and the PMAQ7 adherence behavior scale. Two thirds of the sample...

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

  • Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients. Khanlou, Homayoun; Yeh, Vivian; Guyer, Bill; Farthing, Charles // AIDS Patient Care & STDs;Mar2005, Vol. 19 Issue 3, p135 

    Previous investigational data using abacavir (ABC), lamuvidine (3TC), and zidovudine has suggested the possibility of triple nucleoside analogue reverse transcriptase inhibitors (NRTI) therapy as an option in the treatment of HIV infection. We performed a pilot study to assess the potency of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics